Is Dolby Laboratories (DLB) overvalued? · P/E 28, rev $1.35B
Dolby Laboratories (DLB) is a specialty business services company listed on US.
This page asks whether Dolby Laboratories (DLB) looks expensive on cached numbers — not a short thesis.
Latest reported DLB revenue for 2025-09-26 was $1.35B. Net income was $256.5M. Revenue was up 5.9% from 2024-09-27 to 2025-09-26. DLB currently screens at market cap $7.19B and trailing P/E 28.3.
DLB currently screens at market cap $7.19B and trailing P/E 28.3. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next DLB 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the DLB stock page for the full model, not this heading.
Not investment advice.